P-366 Phase I study evaluating flavopiridol (HMR1275, FP) in combination with docetaxel (D) in previously treated non-small cell lung cancer (NSCLC) patients (pts.) (HMR1275B/1008)
- 31 August 2003
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 41, S184
- https://doi.org/10.1016/s0169-5002(03)92334-8
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: